WASHINGTON (Reuters Health) – Schering-Plough Corp. said on Tuesday that it is recalling certain lots of its seasonal allergy drug Claritin-D 12 Hour (loratadine/pseudoephedrine) because

By Karla Gale BOSTON, Massachusetts (Reuters Health) – Incorporating antioxidant-impregnated filters into cigarettes could reduce their health-damaging effects, according to data presented here Friday at

By Karen Pallarito NEW YORK (Reuters Health) – As debate over a Medicare pharmacy benefit continues, a coalition of employers, health plans, drug benefit managers,

NEW YORK (Reuters Health) – Direct-to-consumer prescription drug advertising continues to grow faster than other types of promotion, and physicians should help patients assess its

NEW YORK (Reuters Health) – Most male infertility resulting from a low serum testosterone-to-estradiol ratio can be successfully treated with the selective aromatase inhibitor, anastrozole,

By Charnicia E. Huggins NEW YORK (Reuters Health) – Young sickle cell patients with delayed growth and maturation may benefit from zinc supplements, according to

By Martha Kerr SAN ANTONIO (Reuters Health) – Studies in rats show that sildenafil citrate (Viagra, Pfizer) has the ability to induce neurogeneration, angiogenesis, and

WASHINGTON (Reuters Health) – Schering-Plough Corp. said on Monday that it received a supplementary approval from the US Food and Drug Administration (FDA) to market

By Merritt McKinney NEW YORK (Reuters Health) – A phenomenon called the "nocebo effect" may explain why some people report side effects that are not

By John Griffiths LONDON (Reuters Health) – There is little evidence that over-the-counter (OTC) cough medicines are effective, British researchers said on Friday. Drs. Knut

By Ned Stafford FRANKFURT, Germany (Reuters Health) – Physicians in Germany this week fired the first shots of what could be a war over whether

NEW YORK (Reuters Health) – Preventive treatment with melatonin provided complete relief in two patients with long-standing chronic cluster headache, clinicians at the Thomas Jefferson

By C. Vidyashankar, MD DELHI (Reuters Health) – Polymerase chain reaction can be used for the early diagnosis of infections caused by Haemophilus influenzae Type

By Pam Harrison TORONTO (Reuters Health) – The use of ACE inhibitors in patients admitted to hospitals for congestive heart failure can be significantly enhanced

STOCKHOLM (Reuters) – St. John's work, an herbal product used to treat mild depression, may counter the effect of oral contraceptive pills (OCPs) and has

By Julie Rovner WASHINGTON (Reuters Health) – More appropriate use of generic medications, particularly to treat ulcers and arthritis, could reduce the pricetag of a

NEW YORK (Reuters Health) – IV valproate appears to be a safe and effective alternative to dihydroergotamine/metoclopramide (DHE/MCLP) for the acute treatment of migraine, according

By Richard Woodman LONDON (Reuters Health) – The new cyclooxygenase 2 (COX-2) inhibitors, commonly prescribed for arthritis pain, can cause gastric problems, which justifies the

LONDON (Reuters Health) – Swiss healthcare group Roche said on Wednesday it has stopped marketing Valium (diazepam) in Britain because it is no longer commercially

By David Douglas NEW YORK (Reuters Health) – The use of inhaled fluticasone propionate, rather than of bronchodilators alone, is cost effective in the treatment